HomeProductsBuilding BlocksHeterocyclic ScaffoldsAromatic HeterocyclesQuinine
Chemical structure of CAS 130-95-0

Quinine

In Stock•Starting at $7 for 1 g•Purity ≥ 97%
CAS No.130-95-0
MDL No.MFCD00198096
MFC20H24N2O2
MW324.40
InChI KeyLOUPRKONTZGTKE-WZBLMQSHSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 g98%$7In Stock
5 g97%$8In Stock
10 g97%$9In Stock
25 g97%$17In Stock
100 g97%$59In Stock
1 kg98%$547In Stock
5 kg98%$2356In Stock
10 kg98%$4458In Stock
25 kg98%$11138In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Quinine is a cinchona alkaloid derived from (8S)-cinchonan hydride, characterized by a methoxy group at the 6-position of the quinoline ring. It functions as an antimalarial, muscle relaxant, and non-narcotic analgesic, and is the conjugate base of quinine(1+).

CAS No.130-95-0
Product NameQuinine

Associated Conditions

Plasmodium falciparum malaria·kidney disease·muscle cramp·Immunodeficiency·Chronic pain·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences • Vol. 12, Issue 3 • 2001
PMID: 11113639DOI: 10.1016/s0928-0987(00)00117-2

Taste responses in sons of male alcoholics.

Alcohol and alcoholism (Oxford, Oxfordshire) • Vol. 36, Issue 1 • 2001
PMID: 11139421DOI: 10.1093/alcalc/36.1.79

Redox systems as conduits for antimalarial compounds.

The Journal of antimicrobial chemotherapy • Vol. 47, Issue 1 • 2001
PMID: 11152448DOI: 10.1093/jac/47.1.122

Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: a Southwest Oncology Group Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • Vol. 19, Issue 3 • 2001
PMID: 11157027DOI: 10.1200/JCO.2001.19.3.750

Documentation

Similar Products